Induction of apoptosis by icariside II through extrinsic and intrinsic signaling pathways in human breast cancer MCF7 cells

Bioscience, Biotechnology and Biochemistry

Volumn 76, Issue 7, 2012, Pages 1322-1328

  Huang, Chaoqing ^a   Chen, Xiaoguang ^b   Guo, Baolin ^a   Huang, Wenhua ^a   Shen, Ting ^c   Sun, Xinguang ^a   Xiao, Peigen ^a   Zhou, Qing ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c Kangwon National University   (South Korea)

Author keywords

Apoptosis; Bcl 2 family protein; Breast cancer; Epimedium; Icari side II

Indexed keywords

ANTI-CANCER AGENTS; ANTITUMOR EFFECT; APOPTOSIS PATHWAYS; APOPTOSIS-INDUCING FACTORS; BCL-2 FAMILY PROTEINS; BREAST CANCER; CYTOCHROME C; EPIMEDIUM; EXPRESSION LEVELS; FAS-ASSOCIATED DEATH DOMAINS; FLAVONOL GLYCOSIDES; HUMAN BREAST CANCER; ICARI-SIDE II; INDUCED APOPTOSIS; MCF-7 CELLS; MITOCHONDRIAL MEMBRANE POTENTIAL; SIGNALING PATHWAYS; UNDERLYING MECHANISM;

DISEASES; SUGARS;

CELL DEATH;

AIFM1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE 8; CASPASE 9; CYTOCHROME C; FADD PROTEIN, HUMAN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS PROTEIN, HUMAN; FLAVONOID; ICARISID II; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST TUMOR; CARCINOMA; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BREAST NEOPLASMS; CARCINOMA; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CYTOCHROMES C; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EPIMEDIUM;

EID: 84864249014     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.120077     Document Type: Article

References (54)

1. Makin G and Dive C, Breast Cancer Res., 3, 150-153 (2001).
2. Ghobrial IM, Witzig TE, and Adjei AA, CA Cancer J. Clin., 55, 178-194 (2005).
3. Hengartner M, Nature, 407, 770-776 (2000).
4. Igney FH and Krammer PH, Nat. Rev. Cancer, 2, 277-288 (2002).
5. Evan GI and Vousden KH, Nature, 411, 342-348 (2001).
6. Wu H, Lien EJ, and Lien LL, Prog. Drug Res., 60, 1-57 (2003).
7. Ma HP, He XR, Yang Y, Li MX, Hao DJ, and Jia ZP, J. Ethnopharmacol., 134, 519-541 (2011).
8. Mizuno M, Hanioka S, Suzuki N, Linuma M, Tanaka T, Liu XS, and Min ZD, Phytochem., 26, 861-863 (1987).
9. Park JS, Park HY, Rho HS, Ahn S, Kim DH, and Chang IS, J. Microbiol. Biotechnol., 18, 110-117 (2008).
10. Dell'Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E, Pagliuca G, and Bosisio E, J. Nat. Prod., 71, 1513-1517 (2008).
11. Cho NJ, Sung SH, Lee HS, Jeon MH, and Kim YC, Arch. Pharm. Res., 18, 289-292 (1995).
12. Huang J, Yuan L, Wang X, Zhang TL, and Wang K, Life Sci., 81, 832-840 (2007).
13. Kuroda M, Mimaki Y, Sashida Y, Umegaki E, Yamazaki M, Chiba K, Mohri T, Kitahara M, Yasuda A, Naoi N, Xu ZW, and Li MR, Planta Med., 66, 575-577 (2000).
14. Cai WJ, Huang JH, Zhang SQ, Wu B, Kapahi P, Zhang XM, and Shen ZY, Plosone, 6, e28835 (2011).
15. Lin X, Li WK, and Xiao PG, Pharm. Pharmacol. Commun., 5, 701-703 (1999).
16. Choi HJ, Eun JS, Kim DK, Li RH, Shin TY, Park H, Cho NP, and Soh Y, Eur. J. Pharmacol., 579, 58-65 (2008).
17. Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, and Kim SH, Cancer Lett., 280, 93-100 (2009).
18. Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung JH, Yun SM, Han I, Lee SG, Kim DK, Kang M, Chen CY, Lee JW, and Kim SH, Eur. J. Pharmacol., 654, 10-16 (2011).
19. Yap SP, Shen P, Butler MS, Gong YH, Loy CJ, and Yong EL, Planta Med., 71, 114-119 (2005).
20. Guo YM, Zhang XT, Meng J, and Wang ZY, Eur. J. Pharmacol., 658, 114-122 (2011).
21. Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST, Wang YP, Hou Y, Sheng J, and Sun QY, Plosone, 6, e16781 (2011).
22. Huang X, Zhu DY, and Lou YJ, Eur. J. Pharmacol., 564, 26-36 (2007).
23. Yang JX, Fichtner I, Becker M, Lemm M, and Wang XM, Am. J. Chin. Med., 37, 1153-1165 (2009).
24. He J, Wang Y, Duan F, Jiang H, Chen MF, and Tang SY, Planta Med., 76, 1834-1839 (2010).
25. Li SG, Dong P, Wang JW, Zhang J, Gu J, Wu XS, Wu WG, Fei XZ, Zhang ZP, Wang Y, Quan ZW, and Liu YB, Cancer Lett., 298, 222-230 (2010).
26. Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, and Chern CL, Food Chem. Toxicol., 44, 227-235 (2006).
27. Liu XS, Kim CN, Yang J, Jemmerson R, and Wang XD, Cell, 86, 147-157 (1996).
28. Wang HB, Li HY, Zuo MX, Zhang Y, Liu H, Fang WS, and Chen XG, Cancer Lett., 268, 89-97 (2008).
29. Eloy L, Jarrousse AS, Teyssot ML, Gautier A, Morel L, Jolivalt C, Cresteil T, and Roland S, Chem. Med. Chem., doi: 10.1002/cmdc.201200055 (2012).
30. Patel T, Gores GJ, and Kaufmann SH, FASEB J., 10, 587-597 (1996).
31. Henry-Mowatt J, Dive C, Martinou JC, and James D, Oncogene, 23, 2850-2860 (2004).
32. Crompton M, Biochem. J., 341, 233-249 (1999).
33. Chinnaiyan AM, O'Rourke K, Tewari M, and Dixit VM, Cell, 81, 505-512 (1995).
34. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, and Dixit VM, J. Biol. Chem., 271, 4961-4965 (1996).
35. Yang X, Khosravi-Far R, Chang HY, and Baltimore D, Cell, 89, 1067-1076 (1997).
36. Khelifi AF, D'Alcontres MS, and Salomoni P, Cell Death Differ., 12, 724-733 (2005).
37. Tang DM, Lahti JM, and Kidd VJ, J. Biol. Chem., 275, 9303-9307 (2000).
38. Tani E, Kitagawa H, Ikemoto H, and Matsumoto T, FEBS Lett., 504, 53-58 (2001).
39. Malki A, EI-Saadani M, and Sultan AS, Cancer Biol. Ther., 8, 2174-2184 (2009).
40. Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, and Pantazis P, Cancer Res., 61, 7148-7154 (2001).
41. Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A, Newton K, Tschopp J, and Strasser A, Proc. Natl. Acad. Sci. USA, 96, 14871-14876 (1999).
42. Micheau O, Solary E, Hammann A, and Dimanche-Boitrel MT, J. Biol. Chem., 274, 7987-7992 (1999).
43. Gajate C, Fonteriz RI, Cabaner C, Alvarez-Noves G, Alvarez-Rodriguez Y, Modolell M, and Mollinedo F, Int. J. Cancer, 85, 674-682 (2000).
44. Watabe M, Hishikawa K, Takayanagi A, Shimizu N, and Nakaki T, J. Biol. Chem., 279, 6017-6026 (2004).
45. Cory S and Adams JM, Nat. Rev. Cancer, 2, 647-656 (2002).
46. Festjens N, van Gurp M, van Loo G, Saelens X, and Vandenabeele P, Acta Haematol., 111, 7-27 (2004).
47. Li HL, Zhu H, Xu CJ, and Yuan JY, Cell, 94, 491-501 (1998).
48. Chen XY, Ding WX, Ni HM, Gao WT, Shi YH, Gambotto AA, Fan J, Beg AA, and Yin XM, Mol. Cell. Biol., 27, 541-553 (2007).
49. Medema JP, Scaffidi C, Krammer PH, and Peter ME, J. Biol. Chem., 273, 3388-3393 (1998).
50. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, and Peter ME, EMBO J., 17, 1675-1687 (1998).
51. Srinivasan A, Li F, Wong A, Kodandapani L, Smidt RJr, Krebs JF, Fritz LC, Wu JC, and Tomaselli KJ, J. Biol. Chem., 273, 4523-4529 (1998).
52. Stegh AH, Barnhart BC, Volkland J, Algeciras-Schimnich A, Ke N, Reed JC, and Peter ME, J. Biol. Chem., 277, 4351-4360 (2002).
53. Shen P, Wong SP, Li J, and Yong EL, J. Chromatogr. B, 877, 71-78 (2009).
54. Zhang YP, Xu W, Li N, Li HY, Shen ZY, Zhang XM, Yang M, Zhang WD, and Zhang C, Chromatographia, 68, 245-250 (2008).